Diversified medical technology company: Vaso Corporation (VASO)

Vaso Corporation (NASDAQ: VASO) was founded in 1987, formerly known as Vasomedical, Inc., and changed its current name in November 2016. Headquartered in Plainview, New York, it has 272 full-time employees. Vaso Corporation and its subsidiaries conduct business in the U.S. and international healthcare equipment and information technology industries. On December 7, 2023 OTCQX Vaso Corporation, a diversified medical technology company traded in the market, announced that it plans to adopt Special purpose acquisition company Achari Ventures Holdings Corp. I (NASDAQ: AVHI) was merged and upgraded to NASDAQ.

The article originates from the home of American stocks | encyclopedia of American stocks | account opening and investment of American and Hong Kong stocks- https://www.mg21.com/vaso.html

Vaso Corporation (VASO)

Vaso Corporation (formerly known as Vasomedical, Inc.) is a medical technology company with experience and expertise across different product and service categories, including non-invasive monitoring and treatment equipment, diagnostic imaging equipment, and information technology for enterprise and clinical customers. The article originates from the home of American stocks | encyclopedia of American stocks | account opening and investment of American and Hong Kong stocks- https://www.mg21.com/vaso.html

Vaso Corporation currently operates three different business units in the healthcare and information technology industries: The article originates from the home of American stocks | encyclopedia of American stocks | account opening and investment of American and Hong Kong stocks- https://www.mg21.com/vaso.html

• VasoMedical : VasoMedical, Inc. is committed to the design, manufacture, sales and service of proprietary medical equipment. VasoMedical is the business department of the company's proprietary medical equipment, which is used for non-invasive monitoring, diagnosis and treatment of certain cardiovascular diseases. Engineering and production activities are mainly carried out in its factories in China, while marketing, sales and services are directly managed by the company's offices in the United States and China or through partners around the world.
• VasoHealthcare : Vaso Diagnostics, Inc. (conducting business in the name of VasoHealthcare) provides professional sales services for diagnostic imaging equipment. VasoHealthcare focuses on providing professional sales representative services for capital medical equipment, and is specialized in providing sales representative services for diagnostic imaging equipment for the medical mid market in the mainland of the United States, including independent hospitals, imaging centers and multi department clinics. VasoHealthcare has been a world leader in medical imaging technology since 2010 GE Healthcare (GEHC) maintain partnership.
• VasoTechnology : VasoTechnology, Inc. (through its two subsidiaries, VasoHealthcare IT Corp. and NetWolves Network Services LLC) provides managed IT systems and services, including healthcare Software Solutions and network connectivity services. VasoTechnology is a solution company focused on providing reliable and secure network connectivity, mission critical applications, data storage and security services for enterprise and healthcare customers. As an engineering and technical expert, the company provides healthcare and commercial IT infrastructure for different vertical markets in the United States and the world through managed professional services.

The listing of Vaso Corporation (VASO)

Vaso Corporation was listed in 1995 and traded on the OTCQX market before announcing the merger and upgrading with the special purpose acquisition company in 2023. The article originates from the home of American stocks | encyclopedia of American stocks | account opening and investment of American and Hong Kong stocks- https://www.mg21.com/vaso.html

December 7, 2023 - Vaso Corporation, a diversified medical technology company, currently trading in the OTCQX market, announced today that it plans to upgrade from the OTCQX to the NASDAQ securities market through business merger with Achari Ventures Holdings Corp. I (NASDAQ: AVHI). After the completion of the transaction, it is expected that Vaso common shares and warrants will be listed in the NASDAQ capital market with the stock codes of "VASO" and "VASOW" respectively. Vaso's common shares will continue to be traded on the OTCQX market until the proposed business portfolio is completed and listed on NASDAQ. The article originates from the home of American stocks | encyclopedia of American stocks | account opening and investment of American and Hong Kong stocks- https://www.mg21.com/vaso.html

The valuation of Vaso in this transaction is about $176 million. The board of directors of Vaso and Achari have approved this transaction, which is expected to be completed in the first quarter of 2024. The article originates from the home of American stocks | encyclopedia of American stocks | account opening and investment of American and Hong Kong stocks- https://www.mg21.com/vaso.html

Vaso Corporation (VASO) US equity investment